Immunohistochemistry Can Act as a Surrogate to Aid Difficult Diagnoses of Soft Tissue Tumors
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
In a demonstration, the technique distinguished between healthy samples and either cancerous or pre-cancerous cells with nearly 100 percent accuracy.
The IVD-grade TIGIT antibody for immunohistochemistry clinical application is available in a concentrate format as well as a ready-to-use predilute format.
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreThe May 2019 Product Spotlight includes anatomic and digital pathology instruments and analyzers from companies such as OptraScan, Proscia, and BioGenex Laboratories.
Read MoreSerological testing plays a critical role in helping diagnose patients with celiac disease.
Read MoreThe manufacturer provides custom anatomical and pathology equipment.
Read MoreValent is the first open-system, fully automated IHC staining platform, merging high-throughput and quality staining with an intuitive user interface.
Read MoreThe partnership aims to facilitate the development of in situ hybridization applications for Lunaphore’s platform, and to achieve shorter turnaround times by using advanced automation technologies.
Read MoreThis month’s issue features a flow cytometer from Bio-Rad Laboratories, laboratory labels from DWK Life Sciences, and a cassette printer from Primera Healthcare.
Read MoreThis month’s issue features a cassette printer from Primera Technology, an advanced cholesterol test from VAP Diagnostics, and a next-generation sequencing module from Qlucore.
Read MoreThis month’s issue features an intelligent pipette stand from Mettler Toledo, a blood collection device from Seventh Sense Biosystems, and a herpes simplex assay from Hologic.
Read MoreThe unit uses thermal-transfer ink ribbons rather than solvent inkjet or laser ablation.
Read MoreThis month’s issue features anatomic and digital pathology technologies from such companies as BioGenex, Indica Labs, and MicroDimensions.
Read MoreThe assay is intended for laboratory use to detect the anaplastic lymphoma kinase protein in formalin-fixed, paraffin-embedded, non-small cell lung carcinoma tissue stained using the Ventana BenchMark XT or Ventana BenchMark Ultra automated immunohistochemical slide strainers.
Read MoreThis month’s issue features anatomic and digital pathology technologies from such companies as Aspyra, Leica Biosystems, Mikroscan Technologies, and Philips.
Read MoreThe collaboration will provide custom solutions that meet data and regulatory requirements for both biopharmaceutical clients and academic medical center oncology programs.
Read MoreThe fully automated hematoxylin and eosin tissue staining system eliminates the use of xylene and alcohol, reducing technician exposure to harmful chemicals.
Read More